Related Experiment Video
Updated: Jun 23, 2025
10:25
Real-time Bioluminescence Imaging of Notch Signaling Dynamics during Murine Neurogenesis
Published on: December 12, 2019
7.6K
Neurobeachin regulates hematopoietic progenitor differentiation and survival by modulating Notch activity
Miguel Ganuza1, Antonio Morales-Hernández2, Alanna Van Huizen3
1Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
Blood Advances
|June 21, 2024
Summary
Neurobeachin (NBEA) and related proteins are crucial for hematopoietic stem cell transplantation (HSCT) success. NBEA regulates NOTCH receptor turnover via vesicle trafficking, ensuring efficient blood system reconstitution.
Area of Science:
- Hematology
- Molecular Biology
- Cell Biology
Background:
- Hematopoietic stem cell transplantation (HSCT) is vital for treating blood disorders.
- Understanding molecular regulators of HSCT is key to improving transplant outcomes.
Purpose of the Study:
- To investigate the role of Beige and Chediak-Higashi domain-containing proteins (BDCPs), specifically Neurobeachin (NBEA), in HSCT.
- To elucidate the molecular mechanisms by which NBEA influences hematopoietic system reconstitution.
Main Methods:
- Knockdown of Nbea in mouse hematopoietic stem cells (HSCs).
- Assessment of HSC apoptosis and differentiation post-transplantation.
- Analysis of gene expression in hematopoietic progenitor cells.
- Evaluation of NOTCH receptor localization and transcriptional program activity.
Main Results:
- NBEA and related BDCPs (LRBA, NBEAL1, LYST) are essential for efficient hematopoietic reconstitution in mice after HSCT.
- Nbea knockdown in HSCs led to increased apoptosis and impaired differentiation.
- Nbea deficiency altered gene expression related to vesicle trafficking and NOTCH receptor localization.
- Perturbation of the NOTCH pathway was observed in Nbea-deficient cells, impacting HSC engraftment.
Conclusions:
- NBEA plays a novel role in controlling NOTCH receptor turnover in hematopoietic cells.
- BDCP-mediated vesicle trafficking is critical for effective HSCT.
- NBEA is a potential therapeutic target for enhancing HSCT efficacy.
More Related Videos
Related Concept Videos
03:14Notch Signaling Pathway
4.2K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.2K
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
01:19Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
01:28Role of Hematopoietic Growth Factors
1.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.3K